Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New CD80 antagonists and their use claimed by Avidex

Nov. 3, 2004

New vitamin D analogues and their use in bone diseases, cancer, etc.

Nov. 3, 2004

Novel Src kinase inhibitors covered by AstraZeneca patent

Nov. 3, 2004

New atherosclerosis vaccine developed by GSK team

Nov. 3, 2004

Novel CDK2/CDK5 inhibitors claimed by IRM researchers

Nov. 2, 2004

AstraZeneca scientists design novel gamma-secretase inhibitors

Nov. 2, 2004

Novel Chk1 inhibitors and their use covered by AstraZeneca patent

Nov. 2, 2004

New tubulin polymerization inhibitors prepared and tested at Aventis

Nov. 2, 2004

New melanocortin MC4 agonists under study at Merck

Nov. 2, 2004

Abbott researchers describe new dopamine D3 ligands for schizophrenia and depression

Nov. 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...